IP Verse

Teijin Pharma competitive analysis

Loading summary...

Latest patents of Teijin Pharma opposed by its competitors

Explore Teijin Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP1956014
Jan 16, 2019Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The Same1

Latest publications and patents of Teijin Pharma New

Explore the latest publications and patents granted to Teijin Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Teijin Pharma

EP1956014
Jan 16, 2019Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The SameRevoked
EP2944633
Jan 31, 2018Pyridine DerivativeNo Opposition Filed Within Time Limit

Latest PTAB cases involving Teijin Pharma

Discover the latest PTAB cases involving Teijin Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Teijin Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TEIJIN PHARMA - 1 - -
DR SCHON27 - - -